Dr Farasat Kazmi

I am a Clinical Oncologist specialising in lung cancer treatment, stereotactic ablative radiotherapy (SABR), precision oncology and advanced systemic anti-cancer therapies, including immunotherapy, targeted therapy and chemotherapy. I have over 10 years of dedicated oncology experience across both clinical practice and cancer research, with particular expertise in treating complex and advanced cancers using highly personalised treatment approaches.

My practice at Spire Norwich Hospital in Norfolk focuses on delivering modern, evidence-based cancer care, including advanced radiotherapy techniques such as Lung SABR, as well as access to cutting-edge clinical trials and precision medicine strategies. I am also actively involved in translational and clinical research, helping to develop new cancer treatments and improve outcomes and quality of life for patients.

One of the most important aspects of my practice is supporting patients and their families through what can often be a difficult and overwhelming time. I believe that compassionate, personalised care and clear communication are just as important as the treatment itself. As part of a specialist lung cancer multidisciplinary team (MDT), I work closely with surgeons, respiratory physicians, radiologists, pathologists, specialist nurses and research teams to ensure every patient receives coordinated, evidence-based and highly personalised care. At the centre of everything I do are my patients, ensuring they feel informed, supported and involved in every step of their cancer journey.

I specialise in general lung cancer managemet with specialist interest in personalised treatment planning for early-stage and advanced lung cancers, pleural and peritoneal mesotheliomas, lung stereotactic ablative radiotherapy (SABR) and advanced radiotherapy techniques, immunotherapy, chemotherapy and targeted cancer therapies. I also provide precision oncology and molecularly guided cancer treatments, management of oligometastatic and complex metastatic disease and integration of radiotherapy with systemic anti-cancer therapies.

I have over 10 years of dedicated oncology experience, including specialist oncology practice in both the UK and Singapore, and almost four years of oncology and early-phase clinical trials experience prior to entering formal Clinical Oncology training. My international experience includes radiation and medical oncology training in Singapore and working as a Clinical Research Fellow at the Early Phase Clinical Trials Unit at the Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, where I was involved in the delivery of innovative early-phase cancer therapies and translational oncology research.

My clinical expertise spans advanced radiotherapy techniques, systemic anti-cancer therapies and precision oncology across multiple tumour sites, with a particular focus on lung cancer, Lung SABR and the management of complex and advanced cancers. I have extensive experience delivering personalised cancer treatments using immunotherapy, targeted therapies, chemotherapy and advanced image-guided radiotherapy techniques.

Alongside my clinical practice, I hold active national and international research and leadership roles and have authored more than 40 peer-reviewed oncology publications, including work published in leading journals such as The Lancet Oncology, Cochrane and the Journal of Clinical Oncology. I am Principal Investigator for a number of international clinical trials and have served on several national and international steering committees and research collaborations. I have also led a Cochrane systematic review on next-generation sequencing-guided targeted therapies and served as a member of the Scientific Advisory Committee for the World Conference on Lung Cancer 2025, one of the world’s leading lung cancer meetings.

My research interests include targeted therapies, next-generation sequencing, clinical trial methodology, patient-reported outcomes and improving access to precision medicine in routine cancer care.